Year |
Citation |
Score |
2015 |
Zak M, Liederer BM, Sampath D, Yuen PW, Bair KW, Baumeister T, Buckmelter AJ, Clodfelter KH, Cheng E, Crocker L, Fu B, Han B, Li G, Ho YC, Lin J, et al. Identification of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with no evidence of CYP3A4 time-dependent inhibition and improved aqueous solubility. Bioorganic & Medicinal Chemistry Letters. 25: 529-41. PMID 25556090 DOI: 10.1016/J.Bmcl.2014.12.026 |
0.35 |
|
2014 |
Zheng X, Baumeister T, Buckmelter AJ, Caligiuri M, Clodfelter KH, Han B, Ho YC, Kley N, Lin J, Reynolds DJ, Sharma G, Smith CC, Wang Z, Dragovich PS, Oh A, et al. Discovery of potent and efficacious cyanoguanidine-containing nicotinamide phosphoribosyltransferase (Nampt) inhibitors. Bioorganic & Medicinal Chemistry Letters. 24: 337-43. PMID 24279990 DOI: 10.1016/J.Bmcl.2013.11.006 |
0.322 |
|
2013 |
Newhouse BJ, Wenglowsky S, Grina J, Laird ER, Voegtli WC, Ren L, Ahrendt K, Buckmelter A, Gloor SL, Klopfenstein N, Rudolph J, Wen Z, Li X, Feng B. Imidazo[4,5-b]pyridine inhibitors of B-Raf kinase. Bioorganic & Medicinal Chemistry Letters. 23: 5896-9. PMID 24042006 DOI: 10.1016/J.Bmcl.2013.08.086 |
0.316 |
|
2013 |
Zheng X, Bair KW, Bauer P, Baumeister T, Bowman KK, Buckmelter AJ, Caligiuri M, Clodfelter KH, Feng Y, Han B, Ho YC, Kley N, Li H, Liang X, Liederer BM, et al. Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). Bioorganic & Medicinal Chemistry Letters. 23: 5488-97. PMID 24021463 DOI: 10.1016/J.Bmcl.2013.08.074 |
0.353 |
|
2013 |
Zheng X, Bauer P, Baumeister T, Buckmelter AJ, Caligiuri M, Clodfelter KH, Han B, Ho YC, Kley N, Lin J, Reynolds DJ, Sharma G, Smith CC, Wang Z, Dragovich PS, et al. Structure-based discovery of novel amide-containing nicotinamide phosphoribosyltransferase (nampt) inhibitors. Journal of Medicinal Chemistry. 56: 6413-33. PMID 23859118 DOI: 10.1021/Jm4008664 |
0.342 |
|
2013 |
Gunzner-Toste J, Zhao G, Bauer P, Baumeister T, Buckmelter AJ, Caligiuri M, Clodfelter KH, Fu B, Han B, Ho YC, Kley N, Liang X, Liederer BM, Lin J, Mukadam S, et al. Discovery of potent and efficacious urea-containing nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with reduced CYP2C9 inhibition properties. Bioorganic & Medicinal Chemistry Letters. 23: 3531-8. PMID 23668988 DOI: 10.1016/J.Bmcl.2013.04.040 |
0.338 |
|
2013 |
Zheng X, Bauer P, Baumeister T, Buckmelter AJ, Caligiuri M, Clodfelter KH, Han B, Ho YC, Kley N, Lin J, Reynolds DJ, Sharma G, Smith CC, Wang Z, Dragovich PS, et al. Structure-based identification of ureas as novel nicotinamide phosphoribosyltransferase (Nampt) inhibitors. Journal of Medicinal Chemistry. 56: 4921-37. PMID 23617784 DOI: 10.1021/Jm400186H |
0.33 |
|
2012 |
Ren L, Ahrendt KA, Grina J, Laird ER, Buckmelter AJ, Hansen JD, Newhouse B, Moreno D, Wenglowsky S, Dinkel V, Gloor SL, Hastings G, Rana S, Rasor K, Risom T, et al. The discovery of potent and selective pyridopyrimidin-7-one based inhibitors of B-RafV600E kinase. Bioorganic & Medicinal Chemistry Letters. 22: 3387-91. PMID 22534450 DOI: 10.1016/J.Bmcl.2012.04.015 |
0.327 |
|
2012 |
Mathieu S, Gradl SN, Ren L, Wen Z, Aliagas I, Gunzner-Toste J, Lee W, Pulk R, Zhao G, Alicke B, Boggs JW, Buckmelter AJ, Choo EF, Dinkel V, Gloor SL, et al. Potent and selective aminopyrimidine-based B-Raf inhibitors with favorable physicochemical and pharmacokinetic properties. Journal of Medicinal Chemistry. 55: 2869-81. PMID 22335519 DOI: 10.1021/Jm300016V |
0.363 |
|
2012 |
Ren L, Laird ER, Buckmelter AJ, Dinkel V, Gloor SL, Grina J, Newhouse B, Rasor K, Hastings G, Gradl SN, Rudolph J. Potent and selective pyrazolo[1,5-a]pyrimidine based inhibitors of B-Raf V600E kinase with favorable physicochemical and pharmacokinetic properties Bioorganic and Medicinal Chemistry Letters. 22: 1165-1168. PMID 22196124 DOI: 10.1016/J.Bmcl.2011.11.092 |
0.332 |
|
2011 |
Wenglowsky S, Ahrendt KA, Buckmelter AJ, Feng B, Gloor SL, Gradl S, Grina J, Hansen JD, Laird ER, Lunghofer P, Mathieu S, Moreno D, Newhouse B, Ren L, Risom T, et al. Pyrazolopyridine inhibitors of B-RafV600E. Part 2: structure-activity relationships. Bioorganic & Medicinal Chemistry Letters. 21: 5533-7. PMID 21802293 DOI: 10.1016/J.Bmcl.2011.06.097 |
0.331 |
|
2011 |
Buckmelter AJ, Ren L, Laird ER, Rast B, Miknis G, Wenglowsky S, Schlachter S, Welch M, Tarlton E, Grina J, Lyssikatos J, Brandhuber BJ, Morales T, Randolph N, Vigers G, et al. The discovery of furo[2,3-c]pyridine-based indanone oximes as potent and selective B-Raf inhibitors. Bioorganic & Medicinal Chemistry Letters. 21: 1248-52. PMID 21211972 DOI: 10.1016/J.Bmcl.2010.12.039 |
0.323 |
|
2005 |
Takaoka LR, Buckmelter AJ, LaCruz TE, Rychnovsky SD. Rational synthesis of contra-thermodynamic spiroacetals by reductive cyclizations. Journal of the American Chemical Society. 127: 528-9. PMID 15643869 DOI: 10.1021/Ja044642O |
0.47 |
|
2001 |
Rychnovsky SD, Hata T, Kim AI, Buckmelter AJ. Use of a conformational radical clock for evaluating alkyllithium-mediated cyclization reactions. Organic Letters. 3: 807-10. PMID 11263887 DOI: 10.1021/Ol006866R |
0.633 |
|
2000 |
Buckmelter AJ, Kim AI, Rychnovsky SD. Conformational memory in enantioselective radical reductions and a new radical clock reaction Journal of the American Chemical Society. 122: 9386-9390. DOI: 10.1021/Ja002068K |
0.544 |
|
1999 |
Rychnovsky SD, Buckmelter AJ, Dahanukar VH, Skalitzky DJ. Synthesis, Equilibration, and Coupling of 4-Lithio-1,3-dioxanes: Synthons for syn- and anti-1,3-Diols. The Journal of Organic Chemistry. 64: 6849-6860. PMID 11674695 DOI: 10.1021/Jo9909352 |
0.566 |
|
1999 |
Buckmelter AJ, Powers JP, Rychnovsky SD, Christen DP, Curran DP. Nonequilibrium radical reductions Chemtracts. 12: 635-638. DOI: 10.1021/Ja980857K |
0.53 |
|
Show low-probability matches. |